Skip to main content

Call for Papers - Submit to our Collections

Experience with Private Equity Involvement in IVF Clinics: The Good, The Bad, The Ugly

Edited by:

Paula Amato, MD, Oregon Health & Science University, United States

Tarun Jain, MD, Northwestern Medicine, United States

Submission Status: Open until 11 March 2026

Endometriosis: Advances in Disease Mechanisms, Diagnosis and Management

Edited by:
Paola Viganò, PhD, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy


Submission Status: Open until 27 February 2026

Prevalence, Cost-Effectiveness, and Outcomes of Medical and Social Egg Cryopreservation

Edited by:
Paola Piomboni, PhD, University of Siena, Italy                      
Alice Luddi, PhD, University of Siena, Italy

Submission Status: Open until 1 June 2025

Articles

Featured Collection: Medical and Surgical Treatment of Obesity to Improve Reproductive Health

Obesity is a highly prevalent chronic disease with a significant and complex impact on reproduction and women with obesity are commonly encouraged to lose weight prior to pregnancy to modify their risks. Edited by Dr. Samantha Schon, this collection aims to provide insights into the relationship between obesity, medical and surgical weight loss, and reproduction.

Celebrating World IVF Day 2024

New Content ItemJoin us in commemorating World IVF Day on July 25th with a look back at the most influential articles published in Reproductive Biology and Endocrinology and related blogs on IVF and assisted reproductive technology in the last few years. 

Aims and scope

Reproductive Biology and Endocrinology publishes and disseminates high-quality results from excellent research in the reproductive sciences.

The journal publishes on topics covering gametogenesis, fertilization, early embryonic development, embryo-uterus interaction, reproductive development, pregnancy, uterine biology, endocrinology of reproduction, control of reproduction, reproductive immunology, neuroendocrinology, and human reproductive medicine. 

We will consider manuscripts examining non-human primates, rats, and mice if they inform the human condition. However, we will no longer review studies involving horses, dogs, sheep, cats, cows, pigs, birds, or fish.

Follow us on Twitter at @RBEJournal!Twitter logo © Twitter

Read more about the scope here

Editor profiles

Co-Editor-in-Chief, David B Seifer

David B. Seifer is a Professor of Obstetrics & Gynecology at Yale School of Medicine in the Division of Reproductive Endocrinology and Infertility at Yale New Haven Hospital Medical Center in New Haven, CT (USA). Dr. Seifer is a consultant for the Food and Drug Administration (USA) and has published over 150 medical studies in peer-reviewed journals.

His translational research has focused upon the biology of ovarian function, particularly the aging ovary. This research has resulted in a better understanding of normal and abnormal follicular development during ART and in identifying novel human ovarian growth factors (ie. neurotrophins, inhibin B and AMH) which inform the clinical practice of reproductive medicine. His clinical research has focused upon health care disparities among women with infertility and the role of vitamin D in female reproductive health and polycystic ovarian syndrome.


Co-Editor-in-Chief, Raoul Orvieto

Raoul Orvieto is a full professor of Obstetrics and Gynecology and incumbent of the Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, at the Faculty of Medicine, Tel-Aviv University, Israel. Prof Orvieto is the director of the Division of Reproductive Endocrinology and Infertility, at the Sheba (Tel-Hashomer) Medical Center, Israel. Since 2022, Prof. Orvieto is the president of the Israel Fertility association (IFA). Prof Orvieto is co-Editor-in-Chief of Reproductive Biology and Endocrinology. He has been author and co-author of more than 400 publications in national and international journals. His scientific interests include various aspects of controlled ovarian hyperstimulation (COH); the role of GnRH-analogues, and specifically GnRH agonist versus antagonist in COH for IVF, pre-implantation genetic testing (PGT), triggering final follicular maturation; and several aspects of ovarian hyperstimulation syndrome (OHSS): pathophysiology, prediction, prevention and its relation to the inflammatory response. See a full publication history here.


Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.2
    5-year Journal Impact Factor: 5.3
    Source Normalized Impact per Paper (SNIP): 1.306
    SCImago Journal Rank (SJR): 1.208

    Speed 2024
    Submission to first editorial decision (median days): 5
    Submission to acceptance (median days): 102

    Usage 2024
    Downloads: 1,912,122
    Altmetric mentions: 867

2023 CiteScore Update

We are delighted to announce our 2023 CiteScore of 7.9! Reproductive Biology and Endocrinology remains firmly in Q1 within the Obstetrics & Gynecology and Reproductive Medicine categories. New Content Item